Merck & Co.'s Stock Falls 8.75% Amid Weak Gardasil Sales in China Merck & Co.'s stock faced an 8.75% drop in 2024, linked to reduced Gardasil vaccine sales in China. Explore the impact on Merck's market performance.
Merck & Co. Faces 8.75% Stock Dip in 2024 Merck & Co. (MRK) shares fell 8.75% in 2024 due to declining Gardasil sales in China. Explore the impact on the pharmaceutical giant's market performance.